MYND Life Sciences Inc. MYNDF
0.01 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.045 Day range 0.0675
0.0081 52-week range 0.0675
- YTD
- 0.00%
- 1 year
- -41.30%
News
newsfilecorp.com MYND Life Sciences Announces Shares for Debt Transaction Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to…
newsfilecorp.com MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
newsfilecorp.com MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition Vancouver, British Columbia--(Newsfile Corp. - January 10, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
newsfilecorp.com MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a leader in mental health diagnostics and treatments,…
newsfilecorp.com MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business Vancouver, British Columbia--(Newsfile Corp. - November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
newsfilecorp.com MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc. Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") The Company is pleased to welcome Ms. Laurie Bakke who was…
newsfilecorp.com MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a pioneering biopharmaceutical research and development…
newsfilecorp.com Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), We are delighted to announce the appointment of Mynd Life…
newsfilecorp.com MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc. Potential merger to create new industry leader. Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a…
newsfilecorp.com MYND Life Sciences Announces Update on Payment Obligations Under Unsecured Convertible Debentures MYND Life Sciences was formed to commercialize proprietary biomarker diagnostic tests and novel therapeutics for patients suffering from MDD, TRD and other neuro-inflammatory disorders Vancouver,…